XML 100 R2.htm IDEA: XBRL DOCUMENT
v3.23.2

Pay vs Performance Disclosure - USD ($) | 12 Months Ended
--- | ---
Jun. 30, 2023 | Jun. 30, 2022 | Jun. 30, 2021
Pay vs Performance Disclosure [Table] |  |  |  |  |
Pay vs Performance [Table Text Block] |  | ### Pay vs. Performance As required by SEC rules, we are providing the following information about the relationship between executive compensation actually paid (as defined by SEC rules) and certain financial performance measures. For information about how our Compensation Committee seeks to align executive compensation with the Company’s performance, see “Compensation discussion and analysis.” The amounts in the table below are calculated in accordance with SEC rules and do not represent amounts actually earned or realized by our NEOs.
|  | Summary Compensation |  | Compensation actually |  | Average Summary Compensation |  | Average Compensation |  | Value of Initial Fixed $100 Investment based on: |  |  |  | Company- selected Measure
Fiscal Year |  | Table Total for CEO(1) |  | paid to CEO(2) |  | Table Total for Non-PEO NEOs(1) |  | actually paid to Non-PEO NEOs(2) |  | Company TSR |  | Peer Group TSR(3) |  | Net Income(4) |  | (Organic Revenue)(5)
2023 |  | $ 30,584,644 |  | $ 4,684,176 |  | $ 2,258,387 |  | $ 2,424,680 |  | $ 124.96 |  | $ 126.72 |  | $ 285,442,000 |  | $ 1,134,700
2022 |  | 15,370,549 |  | (6,349,624 | ) | 3,223,063 |  | (2,680,481 | ) | 132.17 |  | 129.72 |  | 263,099,000 |  | 1,113,600
2021 |  | 15,889,896 |  | 105,676,083 |  | 4,950,600 |  | 26,444,391 |  | 171.17 |  | 147.61 |  | 139,585,000 |  | 915,900
(1) | Charles Kummeth was our CEO for each year presented. For FY23, our non-PEO NEOs were Jim Hippel, Will Geist, Kim Kelderman, Shane Bohnen, and Brenda Furlow. For FY22, our non-PEO NEOs were Jim Hippel, Brenda Furlow, Will Geist, Kim Kelderman, and Dave Eansor. For FY21, our non-PEO NEOs were Jim Hippel, Brenda Furlow, Dave Eansor, and Kim Kelderman.
(2) | Amounts reported in this column and in the table below represent the amount of “Compensation Actually Paid” or “CAP” as computed per SEC rules. These amounts do not reflect the actual amount of compensation earned by or paid to the individual(s) during the applicable fiscal year. The following table summarizes the adjustments made to total compensation in accordance with Item 402(v) of Regulation S-K in order to determine the compensation amounts shown in the table above as being “Compensation Actually Paid”.
| For this purpose, the fair value of equity awards was determined pursuant to the Financial Accounting Standards Board’s Accounting Standards Codification (ASC) Topic 718. Assumptions used in the calculation of the fair value are consistent with the stock option valuation model used to determine the amounts reported in the Company’s audited financial statements, included in the Company’s Annual Report on Form 10-K.
| The fair value of unvested time-based share awards, including restricted stock awards and restricted stock units, as well as the valuation of all share-based awards upon vesting, is based upon the closing price for a share of Bio-Techne common stock for the applicable date of measurement. The fair value of unvested performance share awards is based upon the probable outcome of the applicable performance conditions at the time of measurement. The fair value of unvested options, and the fair value received upon the vesting of stock options, is based upon the Black-Scholes option-pricing model as of the date of measurement, consistent with the stock option valuation model used to determine amounts reported in the Company’s Annual Report on Form 10-K.
|  |  | FY23 |  |  | FY22 |  |  | FY21 |
|  |  | CEO |  |  | Non-PEO NEOs |  |  | CEO |  |  | Non-PEO NEOs |  |  | CEO |  |  | Non-PEO NEOs |
| Total from Summary Compensation Table(i) |  |  | 30,584,644 |  |  |  | 2,258,387 |  |  |  | 15,370,549 |  |  |  | 3,223,063 |  |  |  | 15,889,896 |  |  |  | 4,950,600 |
| Subtract: Grant date fair value of option and stock awards granted in the fiscal year(ii) |  |  | (29,325,210 | ) |  |  | (850,075 | ) |  |  | (10,299,362 | ) |  |  | (949,840 | ) |  |  | (11,199,803 | ) |  |  | (1,722,395 | )
| Add: Fair value at fiscal year end of outstanding and unvested option and stock awards granted in the fiscal year(iii) |  |  | 4,318,227 | (6) |  |  | 1,382,025 |  |  |  | 6,472,546 |  |  |  | 1,106,688 |  |  |  | 30,362,017 |  |  |  | 10,602,750 |
| Add/Subtract: Year-over-Year change in fair value of outstanding and unvested option and stock awards granted in prior fiscal years(iv) |  |  | (6,132,401 | ) |  |  | (877,492 | ) |  |  | (22,021,635 | ) |  |  | (5,636,997 | ) |  |  | 64,935,446 |  |  |  | 11,789,651 |
| Add: Vesting date fair value of option and stock awards granted and vesting during the fiscal year(v) |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
| Add/Subtract: Change as of the vesting date (from the end of the prior fiscal year) in fair value of option and stock awards granted in any prior fiscal year for which vesting conditions were satisfied during the fiscal year, less the fair value (as of end of prior fiscal year) of prior year awards that failed to vest(vi) |  |  | 5,238,918 |  |  |  | 633,346 |  |  |  | 4,128,278 |  |  |  | 469,566 |  |  |  | 5,688,527 |  |  |  | 823,785 |
| Subtract: Awards granted in prior years that did not meet the applicable vesting conditions during the fiscal year(vii) |  |  | — |  |  |  | (121,511 | ) |  |  | — |  |  |  | (892,961 | ) |  |  | — |  |  |  | — |
| Compensation Actually Paid |  |  | 4,684,176 |  |  |  | 2,424,680 |  |  |  | (6,349,624 | ) |  |  | (2,680,481 | ) |  |  | 105,676,083 |  |  |  | 26,444,391 |
| (i) | Represents Total Compensation as reported in the Summary Compensation Table for each fiscal year.
| (ii) | Represents Stock Awards and Option Awards from the Summary Compensation Table for each fiscal year.
| (iii) | Represents the aggregate fair value as of each fiscal year-end of outstanding and unvested option and stock awards granted during the covered fiscal year, computed in accordance with the Company’s methodology used for financial reporting purposes.
| (iv) | Represents the aggregate change in fair value during each fiscal year of the outstanding and unvested option and stock awards granted in prior fiscal years and held as of the last day of the covered fiscal year, computed in accordance with the Company’s methodology used for financial reporting purposes.
| (v) | Represents the aggregate fair value as of the vesting date of for each option and stock award that was granted and vested during the covered fiscal year, computed in accordance with the Company’s methodology used for financial reporting purposes.
| (vi) | Represents the aggregate change in fair value, measured from the prior fiscal year-end to the vesting date, of each option and stock award that was granted in a prior fiscal year and which vested during the covered fiscal year, computed in accordance with the Company’s methodology used for financial reporting purposes.
| (vii) | Represents the fair value as of the end of the prior fiscal year of option and stock awards that were granted in any prior fiscal year that failed to meet the applicable vesting conditions during the covered fiscal year, computed in accordance with the Company’s methodology used for financial reporting purposes. These options and stock awards relate to retirements during the applicable fiscal year.
(3) | The Peer Group TSR in the table utilizes the S&P 500 LifeSciences Tools and Services (“S&P 500 LifeSciences”) Index, which the company also utilizes in the stock performance graph required by Item 201(e) of Regulation S-K included in the fiscal year 2023 Form 10-K. The comparison assumes $100 (including reinvested dividends) was invested for the period starting June 30, 2020 through June 30, 2023 in the company and in the S&P 500 LifeSciences Index, respectively. Historical stock performance is not necessarily indicative of future stock performance.
(4) | Net income represents “Net earnings, including noncontrolling interest” as reported in the Company’s Annual Report on Form 10-K.
(5) | Sales shown reflect organic revenue as calculated for purposes of our executive compensation program for the applicable reporting year. Refer to Appendix A for a reconciliation between GAAP and non-GAAP measures.
(6) | As of June 30, 2023, relates to the time-vesting restricted share units that were granted in fiscal year 2023. As of June 30, 2023, the threshold for the performance-vesting option award related to fiscal year 2023 performance was not achieved. If this award had reached target performance, the fair value as of June 30, 2023 would have been $9.3 million. As of June 30, 2023, the threshold for the performance-vesting option award related to fiscal year 2024 performance has a remote likelihood of achievement. If the most probable outcome of this performance-vesting award was target, the fair value as of June 30, 2023 would be have been $9.3 million for fiscal year 2024 performance.
Company Selected Measure Name |  | organic revenue |  |  |
Named Executive Officers, Footnote [Text Block] |  |
(1) | Charles Kummeth was our CEO for each year presented. For FY23, our non-PEO NEOs were Jim Hippel, Will Geist, Kim Kelderman, Shane Bohnen, and Brenda Furlow. For FY22, our non-PEO NEOs were Jim Hippel, Brenda Furlow, Will Geist, Kim Kelderman, and Dave Eansor. For FY21, our non-PEO NEOs were Jim Hippel, Brenda Furlow, Dave Eansor, and Kim Kelderman.
Changed Peer Group, Footnote [Text Block] |  | The Peer Group TSR in the table utilizes the S&P 500 LifeSciences Tools and Services (“S&P 500 LifeSciences”) Index, which the company also utilizes in the stock performance graph required by Item 201(e) of Regulation S-K included in the fiscal year 2023 Form 10-K. The comparison assumes $100 (including reinvested dividends) was invested for the period starting June 30, 2020 through June 30, 2023 in the company and in the S&P 500 LifeSciences Index, respectively. Historical stock performance is not necessarily indicative of future stock performance. |  |  |
PEO Total Compensation Amount | [1] | $ 30,584,644 |  | $ 15,370,549 | $ 15,889,896
PEO Actually Paid Compensation Amount |  | $ 4,684,176 |  | (6,349,624) | 105,676,083
Adjustment To PEO Compensation, Footnote [Text Block] |  |
|  |  | FY23 |  |  | FY22 |  |  | FY21 |
|  |  | CEO |  |  | Non-PEO NEOs |  |  | CEO |  |  | Non-PEO NEOs |  |  | CEO |  |  | Non-PEO NEOs |
| Total from Summary Compensation Table(i) |  |  | 30,584,644 |  |  |  | 2,258,387 |  |  |  | 15,370,549 |  |  |  | 3,223,063 |  |  |  | 15,889,896 |  |  |  | 4,950,600 |
| Subtract: Grant date fair value of option and stock awards granted in the fiscal year(ii) |  |  | (29,325,210 | ) |  |  | (850,075 | ) |  |  | (10,299,362 | ) |  |  | (949,840 | ) |  |  | (11,199,803 | ) |  |  | (1,722,395 | )
| Add: Fair value at fiscal year end of outstanding and unvested option and stock awards granted in the fiscal year(iii) |  |  | 4,318,227 | (6) |  |  | 1,382,025 |  |  |  | 6,472,546 |  |  |  | 1,106,688 |  |  |  | 30,362,017 |  |  |  | 10,602,750 |
| Add/Subtract: Year-over-Year change in fair value of outstanding and unvested option and stock awards granted in prior fiscal years(iv) |  |  | (6,132,401 | ) |  |  | (877,492 | ) |  |  | (22,021,635 | ) |  |  | (5,636,997 | ) |  |  | 64,935,446 |  |  |  | 11,789,651 |
| Add: Vesting date fair value of option and stock awards granted and vesting during the fiscal year(v) |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
| Add/Subtract: Change as of the vesting date (from the end of the prior fiscal year) in fair value of option and stock awards granted in any prior fiscal year for which vesting conditions were satisfied during the fiscal year, less the fair value (as of end of prior fiscal year) of prior year awards that failed to vest(vi) |  |  | 5,238,918 |  |  |  | 633,346 |  |  |  | 4,128,278 |  |  |  | 469,566 |  |  |  | 5,688,527 |  |  |  | 823,785 |
| Subtract: Awards granted in prior years that did not meet the applicable vesting conditions during the fiscal year(vii) |  |  | — |  |  |  | (121,511 | ) |  |  | — |  |  |  | (892,961 | ) |  |  | — |  |  |  | — |
| Compensation Actually Paid |  |  | 4,684,176 |  |  |  | 2,424,680 |  |  |  | (6,349,624 | ) |  |  | (2,680,481 | ) |  |  | 105,676,083 |  |  |  | 26,444,391 |
Non-PEO NEO Average Total Compensation Amount | [1] | $ 2,258,387 |  | 3,223,063 | 4,950,600
Non-PEO NEO Average Compensation Actually Paid Amount |  | $ 2,424,680 |  | (2,680,481) | 26,444,391
Adjustment to Non-PEO NEO Compensation Footnote [Text Block] |  |
|  |  | FY23 |  |  | FY22 |  |  | FY21 |
|  |  | CEO |  |  | Non-PEO NEOs |  |  | CEO |  |  | Non-PEO NEOs |  |  | CEO |  |  | Non-PEO NEOs |
| Total from Summary Compensation Table(i) |  |  | 30,584,644 |  |  |  | 2,258,387 |  |  |  | 15,370,549 |  |  |  | 3,223,063 |  |  |  | 15,889,896 |  |  |  | 4,950,600 |
| Subtract: Grant date fair value of option and stock awards granted in the fiscal year(ii) |  |  | (29,325,210 | ) |  |  | (850,075 | ) |  |  | (10,299,362 | ) |  |  | (949,840 | ) |  |  | (11,199,803 | ) |  |  | (1,722,395 | )
| Add: Fair value at fiscal year end of outstanding and unvested option and stock awards granted in the fiscal year(iii) |  |  | 4,318,227 | (6) |  |  | 1,382,025 |  |  |  | 6,472,546 |  |  |  | 1,106,688 |  |  |  | 30,362,017 |  |  |  | 10,602,750 |
| Add/Subtract: Year-over-Year change in fair value of outstanding and unvested option and stock awards granted in prior fiscal years(iv) |  |  | (6,132,401 | ) |  |  | (877,492 | ) |  |  | (22,021,635 | ) |  |  | (5,636,997 | ) |  |  | 64,935,446 |  |  |  | 11,789,651 |
| Add: Vesting date fair value of option and stock awards granted and vesting during the fiscal year(v) |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
| Add/Subtract: Change as of the vesting date (from the end of the prior fiscal year) in fair value of option and stock awards granted in any prior fiscal year for which vesting conditions were satisfied during the fiscal year, less the fair value (as of end of prior fiscal year) of prior year awards that failed to vest(vi) |  |  | 5,238,918 |  |  |  | 633,346 |  |  |  | 4,128,278 |  |  |  | 469,566 |  |  |  | 5,688,527 |  |  |  | 823,785 |
| Subtract: Awards granted in prior years that did not meet the applicable vesting conditions during the fiscal year(vii) |  |  | — |  |  |  | (121,511 | ) |  |  | — |  |  |  | (892,961 | ) |  |  | — |  |  |  | — |
| Compensation Actually Paid |  |  | 4,684,176 |  |  |  | 2,424,680 |  |  |  | (6,349,624 | ) |  |  | (2,680,481 | ) |  |  | 105,676,083 |  |  |  | 26,444,391 |
Compensation Actually Paid vs. Total Shareholder Return [Text Block] |  |  |  |  |
Compensation Actually Paid vs. Net Income [Text Block] |  |  |  |  |
Compensation Actually Paid vs. Company Selected Measure [Text Block] |  |  |  |  |
Total Shareholder Return Vs Peer Group [Text Block] |  |  |  |  |
Tabular List [Table Text Block] |  | ## Measures linking pay and performance As described in greater detail in “Compensation discussion and analysis,” our approach to executive compensation is designed to meet the following objectives: attracting and retaining highly qualified executives, tying pay to performance and Company strategy, aligning executives’ incentives with long-term shareholder interests, and encouraging internal pay equity. The unranked list below represents, in the Company’s view, the Company’s two important financial measures used to link compensation to performance in fiscal 2023:
• | Organic Revenue Growth*
• | Adjusted Net Income*
* | These are non-GAAP measures. Appendix A to this Proxy Statement defines these and other non-GAAP financial measures and reconciles them to the most directly comparable historical GAAP financial measures.
Total Shareholder Return Amount |  | $ 124.96 |  | 132.17 | 171.17
Peer Group Total Shareholder Return Amount |  | 126.72 |  | 129.72 | 147.61
Net Income (Loss) Attributable to Parent | [2] | $ 285,442,000 |  | $ 263,099,000 | $ 139,585,000
Company Selected Measure Amount | [3] | 1,134,700 |  | 1,113,600 | 915,900
Measure [Axis]: 1 |  |  |  |  |
Pay vs Performance Disclosure [Table] |  |  |  |  |
Measure Name | [4] | Organic Revenue Growth |  |  |
Measure [Axis]: 2 |  |  |  |  |
Pay vs Performance Disclosure [Table] |  |  |  |  |
Measure Name | [4] | Adjusted Net Income |  |  |
PEO [Member] | Subtract: Grant date fair value of option and stock awards granted in the fiscal year |  |  |  |  |
Pay vs Performance Disclosure [Table] |  |  |  |  |
Adjustment to Compensation Amount | [5] | $ (29,325,210) |  | $ (10,299,362) | $ (11,199,803)
PEO [Member] | Add: Fair value at fiscal year end of outstanding and unvested option and stock awards granted in the fiscal year |  |  |  |  |
Pay vs Performance Disclosure [Table] |  |  |  |  |
Adjustment to Compensation Amount | [7] | 4,318,227 | [6] | 6,472,546 | 30,362,017
PEO [Member] | Add/Subtract: Year-over-Year change in fair value of outstanding and unvested option and stock awards granted in prior fiscal years |  |  |  |  |
Pay vs Performance Disclosure [Table] |  |  |  |  |
Adjustment to Compensation Amount | [8] | (6,132,401) |  | (22,021,635) | 64,935,446
PEO [Member] | Add: Vesting date fair value of option and stock awards granted and vesting during the fiscal year |  |  |  |  |
Pay vs Performance Disclosure [Table] |  |  |  |  |
Adjustment to Compensation Amount | [9] |  |  |  |
PEO [Member] | Add/Subtract: Change as of the vesting date (from the end of the prior fiscal year) in fair value of option and stock awards granted in any prior fiscal year for which vesting conditions were satisfied during the fiscal year, less the fair value (as of end of prior fiscal year) of prior year awards that failed to vest |  |  |  |  |
Pay vs Performance Disclosure [Table] |  |  |  |  |
Adjustment to Compensation Amount | [10] | 5,238,918 |  | 4,128,278 | 5,688,527
PEO [Member] | Subtract: Awards granted in prior years that did not meet the applicable vesting conditions during the fiscal year |  |  |  |  |
Pay vs Performance Disclosure [Table] |  |  |  |  |
Adjustment to Compensation Amount | [11] |  |  |  |
PEO [Member] | Charles Kummeth |  |  |  |  |
Pay vs Performance Disclosure [Table] |  |  |  |  |
PEO Name |  | Charles Kummeth |  | Charles Kummeth | Charles Kummeth
Non-PEO NEO [Member] | Subtract: Grant date fair value of option and stock awards granted in the fiscal year |  |  |  |  |
Pay vs Performance Disclosure [Table] |  |  |  |  |
Adjustment to Compensation Amount | [5] | $ (850,075) |  | $ (949,840) | $ (1,722,395)
Non-PEO NEO [Member] | Add: Fair value at fiscal year end of outstanding and unvested option and stock awards granted in the fiscal year |  |  |  |  |
Pay vs Performance Disclosure [Table] |  |  |  |  |
Adjustment to Compensation Amount | [7] | 1,382,025 |  | 1,106,688 | 10,602,750
Non-PEO NEO [Member] | Add/Subtract: Year-over-Year change in fair value of outstanding and unvested option and stock awards granted in prior fiscal years |  |  |  |  |
Pay vs Performance Disclosure [Table] |  |  |  |  |
Adjustment to Compensation Amount | [8] | (877,492) |  | (5,636,997) | 11,789,651
Non-PEO NEO [Member] | Add: Vesting date fair value of option and stock awards granted and vesting during the fiscal year |  |  |  |  |
Pay vs Performance Disclosure [Table] |  |  |  |  |
Adjustment to Compensation Amount | [9] |  |  |  |
Non-PEO NEO [Member] | Add/Subtract: Change as of the vesting date (from the end of the prior fiscal year) in fair value of option and stock awards granted in any prior fiscal year for which vesting conditions were satisfied during the fiscal year, less the fair value (as of end of prior fiscal year) of prior year awards that failed to vest |  |  |  |  |
Pay vs Performance Disclosure [Table] |  |  |  |  |
Adjustment to Compensation Amount | [10] | 633,346 |  | 469,566 | 823,785
Non-PEO NEO [Member] | Subtract: Awards granted in prior years that did not meet the applicable vesting conditions during the fiscal year |  |  |  |  |
Pay vs Performance Disclosure [Table] |  |  |  |  |
Adjustment to Compensation Amount | [11] | $ (121,511) |  | $ (892,961) |
Non-PEO NEO [Member] | Jim Hippel |  |  |  |  |
Pay vs Performance Disclosure [Table] |  |  |  |  |
PEO Name |  | Jim Hippel |  | Jim Hippel | Jim Hippel
Non-PEO NEO [Member] | Will Geist |  |  |  |  |
Pay vs Performance Disclosure [Table] |  |  |  |  |
PEO Name |  | Will Geist |  | Will Geist |
Non-PEO NEO [Member] | Kim Kelderman |  |  |  |  |
Pay vs Performance Disclosure [Table] |  |  |  |  |
PEO Name |  | Kim Kelderman |  | Kim Kelderman | Kim Kelderman
Non-PEO NEO [Member] | Shane Bohnen |  |  |  |  |
Pay vs Performance Disclosure [Table] |  |  |  |  |
PEO Name |  | Shane Bohnen |  |  |
Non-PEO NEO [Member] | Brenda Furlow |  |  |  |  |
Pay vs Performance Disclosure [Table] |  |  |  |  |
PEO Name |  | Brenda Furlow |  | Brenda Furlow | Brenda Furlow
Non-PEO NEO [Member] | Dave Eansor |  |  |  |  |
Pay vs Performance Disclosure [Table] |  |  |  |  |
PEO Name |  |  |  | Dave Eansor | Dave Eansor
[1] | Represents Total Compensation as reported in the Summary Compensation Table for each fiscal year.
[2] | Net income represents “Net earnings, including noncontrolling interest” as reported in the Company’s Annual Report on Form 10-K.
[3] | Sales shown reflect organic revenue as calculated for purposes of our executive compensation program for the applicable reporting year. Refer to Appendix A for a reconciliation between GAAP and non-GAAP measures.
[4] | These are non-GAAP measures. Appendix A to this Proxy Statement defines these and other non-GAAP financial measures and reconciles them to the most directly comparable historical GAAP financial measures.
[5] | Represents Stock Awards and Option Awards from the Summary Compensation Table for each fiscal year.
[6] | As of June 30, 2023, relates to the time-vesting restricted share units that were granted in fiscal year 2023. As of June 30, 2023, the threshold for the performance-vesting option award related to fiscal year 2023 performance was not achieved. If this award had reached target performance, the fair value as of June 30, 2023 would have been $9.3 million. As of June 30, 2023, the threshold for the performance-vesting option award related to fiscal year 2024 performance has a remote likelihood of achievement. If the most probable outcome of this performance-vesting award was target, the fair value as of June 30, 2023 would be have been $9.3 million for fiscal year 2024 performance.
[7] | Represents the aggregate fair value as of each fiscal year-end of outstanding and unvested option and stock awards granted during the covered fiscal year, computed in accordance with the Company’s methodology used for financial reporting purposes.
[8] | Represents the aggregate change in fair value during each fiscal year of the outstanding and unvested option and stock awards granted in prior fiscal years and held as of the last day of the covered fiscal year, computed in accordance with the Company’s methodology used for financial reporting purposes.
[9] | Represents the aggregate fair value as of the vesting date of for each option and stock award that was granted and vested during the covered fiscal year, computed in accordance with the Company’s methodology used for financial reporting purposes.
[10] | Represents the aggregate change in fair value, measured from the prior fiscal year-end to the vesting date, of each option and stock award that was granted in a prior fiscal year and which vested during the covered fiscal year, computed in accordance with the Company’s methodology used for financial reporting purposes.
[11] | Represents the fair value as of the end of the prior fiscal year of option and stock awards that were granted in any prior fiscal year that failed to meet the applicable vesting conditions during the covered fiscal year, computed in accordance with the Company’s methodology used for financial reporting purposes. These options and stock awards relate to retirements during the applicable fiscal year.

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 3 + Details
Name: | ecd_AdjToCompAmt
Namespace Prefix: | ecd_
Data Type: | xbrli:monetaryItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 3 + Details
Name: | ecd_AdjToNonPeoNeoCompFnTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 3 + Details
Name: | ecd_AdjToPeoCompFnTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph iv + Details
Name: | ecd_ChangedPeerGroupFnTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph vi + Details
Name: | ecd_CoSelectedMeasureAmt
Namespace Prefix: | ecd_
Data Type: | xbrli:decimalItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph vi + Details
Name: | ecd_CoSelectedMeasureName
Namespace Prefix: | ecd_
Data Type: | xbrli:normalizedStringItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 5 -Subparagraph iii + Details
Name: | ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 5 -Subparagraph ii + Details
Name: | ecd_CompActuallyPaidVsNetIncomeTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 5 -Subparagraph i + Details
Name: | ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph vi + Details
Name: | ecd_MeasureName
Namespace Prefix: | ecd_
Data Type: | xbrli:normalizedStringItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 3 + Details
Name: | ecd_NamedExecutiveOfficersFnTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph iii + Details
Name: | ecd_NonPeoNeoAvgCompActuallyPaidAmt
Namespace Prefix: | ecd_
Data Type: | xbrli:monetaryItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph ii + Details
Name: | ecd_NonPeoNeoAvgTotalCompAmt
Namespace Prefix: | ecd_
Data Type: | xbrli:monetaryItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph iv + Details
Name: | ecd_PeerGroupTotalShareholderRtnAmt
Namespace Prefix: | ecd_
Data Type: | xbrli:monetaryItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph iii + Details
Name: | ecd_PeoActuallyPaidCompAmt
Namespace Prefix: | ecd_
Data Type: | xbrli:monetaryItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 3 + Details
Name: | ecd_PeoName
Namespace Prefix: | ecd_
Data Type: | xbrli:normalizedStringItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph ii + Details
Name: | ecd_PeoTotalCompAmt
Namespace Prefix: | ecd_
Data Type: | xbrli:monetaryItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 1 + Details
Name: | ecd_PvpTable
Namespace Prefix: | ecd_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 1 + Details
Name: | ecd_PvpTableTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 6 + Details
Name: | ecd_TabularListTableTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph iv + Details
Name: | ecd_TotalShareholderRtnAmt
Namespace Prefix: | ecd_
Data Type: | xbrli:monetaryItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 5 -Subparagraph iv + Details
Name: | ecd_TotalShareholderRtnVsPeerGroupTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(g)(1)(ii)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 323 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 825 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 28 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (b)(2) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 40 -Name Accounting Standards Codification -Section 65 -Paragraph 1 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 8 -Publisher FASB -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 9 -Publisher FASB -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 11 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 11 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Publisher FASB -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4 Reference 13: http://www.xbrl.org/2003/role/exampleRef -Topic 946 -SubTopic 830 -Name Accounting Standards Codification -Section 55 -Paragraph 10 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10 Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section 45 -Paragraph 7 -Publisher FASB -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7 Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Topic 944 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04(18)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1 Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 22 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22 Reference 17: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-07(9)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1 Reference 18: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-09(1)(d)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3 Reference 19: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(i)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(ii)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A Reference 21: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iii)(A)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A Reference 22: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iv)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A Reference 23: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(5)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A Reference 24: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(i)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B Reference 25: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iii)(A)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B Reference 26: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iii)(B)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B Reference 27: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iv)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B Reference 28: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(5)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B Reference 29: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 30 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30 Reference 30: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32 Reference 31: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 60B -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B Reference 32: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 31 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31 Reference 33: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32 Reference 34: http://www.xbrl.org/2003/role/disclosureRef -Topic 205 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 7 -Publisher FASB -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7 Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 230 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 28 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28 Reference 36: http://www.xbrl.org/2003/role/disclosureRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 1A -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A Reference 37: http://www.xbrl.org/2003/role/disclosureRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 1B -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03(20)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2 Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 942 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-04(22)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1 + Details
Name: | us-gaap_NetIncomeLoss
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | ecd_MeasureAxis=1
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_MeasureAxis=2
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_ExecutiveCategoryAxis=ecd_PeoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_AdjToCompAxis=tech_SubtractGrantDateFairValueOfOptionAndStockAwardsGrantedInTheFiscalYearMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_AdjToCompAxis=tech_AddFairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAndStockAwardsGrantedInTheFiscalYearMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_AdjToCompAxis=tech_AddSubtractYearOverYearChangeInFairValueOfOutstandingAndUnvestedOptionAndStockAwardsGrantedInPriorFiscalYearsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_AdjToCompAxis=tech_AddVestingDateFairValueOfOptionAndStockAwardsGrantedAndVestingDuringTheFiscalYearMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_AdjToCompAxis=tech_AddSubtractChangeAsOfTheVestingDateFromTheEndOfThePriorFiscalYearInFairValueOfOptionAndStockAwardsGrantedInAnyPriorFiscalYearForWhichVestingConditionsWereSatisfiedDuringTheFiscalYearLessTheFairMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_AdjToCompAxis=tech_SubtractAwardsGrantedInPriorYearsThatDidNotMeetTheApplicableVestingConditionsDuringTheFiscalYearMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_IndividualAxis=tech_CharlesKummethMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_IndividualAxis=tech_JimHippelMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_IndividualAxis=tech_WillGeistMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_IndividualAxis=tech_KimKeldermanMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_IndividualAxis=tech_ShaneBohnenMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_IndividualAxis=tech_BrendaFurlowMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_IndividualAxis=tech_DaveEansorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |